Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00074815 · ClinicalTrials.gov registry record · Phase 3
Treatment of Obsessive Compulsive Disorder in Children
A Phase 3 study of Obsessive - Compulsive Disorder, sponsored by Duke University.
- Completed
- Registry status
- Phase 3
- Development phase
- 124
- Enrollment target
- 3
- Study locations
NCT00074815 is a Phase 3 study of Obsessive - Compulsive Disorder that has completed, run by Duke University. The registered enrollment target is 124 participants, below the 2,063-participant average among 84 other Obsessive - Compulsive Disorder trials with a reported enrollment target (94% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT00074815, a Phase 3 study of Obsessive - Compulsive Disorder, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 124 participants
- Enrollment target
- 3
- Study locations
Study Summary
This study will determine whether cognitive behavioral therapy delivered by either psychologists or psychiatrists can improve the effectiveness of serotonin reuptake inhibitor treatment in children with obsessive compulsive disorder.
Conditions Studied
Interventions
- DRUG Serotonin reuptake inhibitors management
- BEHAVIORAL Cognitive behavioral therapy by a psychologist
- BEHAVIORAL Instructional cognitive behavioral therapy by a psychiatrist
Study Locations (3)
North Carolina
- Duke Child and Family Study Center - Durham
Pennsylvania
- University of Pennsylvania, The Center for the Treatment and Study of Anxiety - Philadelphia
Rhode Island
- Rhode Island Hospital - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 124 participants |
| Start Date | 2003-09 |
| Est. Completion | 2009-11 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00074815
The ClinicalTrials.gov registry entry for NCT00074815 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 124 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,063-participant average among 84 other Obsessive - Compulsive Disorder trials with a reported enrollment target (94% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Obsessive - Compulsive Disorder appearing as the primary indexed condition, and to 3 interventions - of which Serotonin reuptake inhibitors management is the first listed.
NCT00074815 reports 3 study locations spanning 3 distinct geographic areas - top geographies include North Carolina, Pennsylvania, Rhode Island.
Frequently Asked Questions
What is clinical trial NCT00074815 about?
NCT00074815 is a clinical study titled "Treatment of Obsessive Compulsive Disorder in Children". This study will determine whether cognitive behavioral therapy delivered by either psychologists or psychiatrists can improve the effectiveness of serotonin reuptake inhibitor treatment in children with obsessive compulsive disorder.
What is the current status of trial NCT00074815?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 124 participants. The study started on 2003-09. Estimated completion is 2009-11.
What conditions does trial NCT00074815 study?
This clinical trial studies the following conditions: Obsessive - Compulsive Disorder.
What interventions are being tested in trial NCT00074815?
The interventions under investigation include: Serotonin reuptake inhibitors management (DRUG), Cognitive behavioral therapy by a psychologist (BEHAVIORAL), Instructional cognitive behavioral therapy by a psychiatrist (BEHAVIORAL).
Who is sponsoring clinical trial NCT00074815?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00074815 being conducted?
This trial has 3 study locations across North Carolina, Pennsylvania, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obsessive - Compulsive Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Efficacy and Safety Study of Adjunctive Troriluzule in Obsessive Compulsive Disorder
COMPLETED · Phase 3
-
Treatment of Obsessive-Compulsive Disorder (OCD) in Children
COMPLETED · Phase 3
-
Family Based Treatment of Early Childhood Obsessive Compulsive Disorder
COMPLETED · Phase 3
-
Memantine Treatment for Obsessive-compulsive Disorder and Generalized Anxiety Disorder
COMPLETED · Phase 3
-
Comparing the Effectiveness of Two Family-based Therapies in Treating Young Children With Obsessive-Compulsive Disorder
COMPLETED · Phase 3
-
Transcranial Magnetic Stimulation and Psychotherapy for Treating Obsessive-Compulsive Disorder
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.